PatientSafe Solutions Partners with ILÚM Health Solutions to Deploy Infectious Disease Notifications in the PatientTouch Platform


Leading infectious disease management solutions provider integrates with PatientSafe’s established communications and workflow technology to expedite delivery of critical notifications for antimicrobial stewardship and sepsis.

SAN DIEGO–(BUSINESS WIRE)–PatientSafe Solutions, a leader in mobile clinical communication and workflow solutions, announced today it has partnered with ILÚM Health Solutions, a wholly-owned subsidiary of Merck’s Healthcare Services and Solutions division, to expedite delivery of infectious disease alerts to clinicians.

“We are excited to combine PatientTouch’s strength in delivering real-time clinical information to the care team’s secure mobile devices with ILÚM’s ability to rapidly extract and synthesize critical data from the pharmacy and lab. Our integration will enable PatientTouch hospitals to help improve adherence to established clinical pathways for antimicrobial stewardship (AMS) and sepsis, leading to better infectious disease outcomes,” said Si Lou, president and CEO, Patient Safe Solutions.

The ILÚM technology analyzes patient data in accordance with institution-specific guidelines and highlights high-risk patients and intervention opportunities, decreasing cognitive load on the care team. Notifications from ILÚM are routed in real-time to the assigned caregiver or on-call AMS team, enabling immediate triage and rapid coordination between the care team and pharmacy for medication changes – all in one smartphone application.

“Clinicians have to handle a high volume and velocity of information to effectively manage patients with infectious diseases. They need access to real-time clinical, pharmacy and lab information in addition to synthesized results and insights about when and where to intervene,” said Dr. Brandon Palermo, ILÚM CMO. “With this collaboration, our companies have an opportunity to rapidly get the right information to the right people, optimizing clinical, economic and most importantly, patient outcomes.”

“Our companies have a very natural and exciting synergy. We both understand the criticality of rapid response and the growing need to deliver information in an expedited, mobile format consistent with the way care teams work,” said Paul Edwards, ILÚM CEO. “Because PatientSafe has a well-established clinical communication and workflow platform and can dynamically identify the right care team member in real-time, we can now get the right alert into the right hands to help hospitals improve outcomes and reduce the cost of care.”

About PatientSafe Solutions

PatientSafe Solutions (San Diego, California) obsesses over the experience of care to help care teams communicate and work together reliably and efficiently. PatientSafe delivers measurable safety and quality improvements through a mobile platform that extends an organization’s EHR, clinical, and communication infrastructure and fits seamlessly into care team workflows. The company’s context-driven PatientTouch® platform unifies communication with workflow by consolidating text, talk, alerts, EMR data, clinical workflows and customizable care interventions, all in one mobile app, on one device. For more than a decade, PatientTouch has helped clinicians both in and outside the hospital streamline care delivery, increase quality, and lower costs. Visit PatientSafe Solutions at and connect with us on Twitter and LinkedIn.

About ILÚM Health Solutions

ILÚM Health Solutions is a provider of technology and services to support infectious disease management. ILÚM is part of Healthcare Services & Solutions, LLC, a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada), an independent business unit focused on improving the value of care delivered to patients through evidence-based services and solutions. ILÚM is organized and managed independently from Merck’s pharmaceutical products business. For more information, visit www.ILÚ and connect with us on Twitter and LinkedIn.